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Abstract
The prevailing method of analyzing GWAS data is still to test
each marker individually, although from a statistical point of view
it is quite obvious that in case of complex traits such single marker
tests are not ideal. Recently several model selection approaches for
GWAS have been suggested, most of them based on LASSO-type pro-
cedures. Here we will discuss an alternative model selection approach
which is based on a modification of the Bayesian Information Crite-
rion (mBIC2) which was previously shown to have certain asymptotic
optimality properties in terms of minimizing the misclassification er-
ror. Heuristic search strategies are introduced which attempt to find
the model which minimizes mBIC2, and which are efficient enough to
allow the analysis of GWAS data.
Our approach is implemented in a software package called MOS-
GWA. Its performance in case control GWAS is compared with the two
algorithms HLASSO and GWASelect, as well as with single marker
tests, where we performed a simulation study based on real SNP data
from the POPRES sample. Our results show that MOSGWA performs
slightly better than HLASSO, whereas according to our simulations
GWASelect does not control the type I error when used to automat-
ically determine the number of important SNPs. We also reanalyze
the GWAS data from the Wellcome Trust Case-Control Consortium
(WTCCC) and compare the findings of the different procedures.
The program is available at http://mosgwa.sourceforge.net/. An
application note describing the software in more detail is in prepara-
tion.
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The data set used for simulations in this manuscript was obtained
from dbGaP through dbGaP accession number phs000145.v1.p1 at
www.ncbi.nlm.nih.gov/projects/gap/cgibin/study.cgi?study id=phs000145.v1.p1.
The WTCCC data is available at http://www.wtccc.org.uk/.
1 Introduction
Recently there has been growing interest in model selection approaches to
GWAS analysis. Although it is still common practice in published GWAS
to perform statistical analysis for each SNP individually, there is increasing
awareness that this kind of single marker analysis has certain deficiencies
in case of complex traits. Several authors have commented that marginal
tests will suffer from lack of power to detect SNPs because the effect of other
causal SNPs remains unaccounted for (see for example Hoggart et al. (2008);
Frommlet et al. (2012b)). It has been argued that this shortcoming of single
marker tests might play a significant role in the widely discussed phenomenon
of “missing heritability” in GWAS (Yang et al., 2010).
A slightly more sophisticated and less known problem has been pointed
out by Frommlet et al. (2012b), namely that single marker tests have serious
difficulties to rank important SNPs correctly. This is obvious for SNPs which
are not directly associated with a trait, but which have an important effect
conditional on the presence of other SNPs. However, even in case of SNPs
with marginal effects it turns out that due to small sample correlations some
important SNPs might have rather small probability to be detected, whereas
other SNPs which are not associated at all with the trait might be selected
with large probability. This result puts in question the common practice to
report those SNPs in GWAS which have lowest ranking marginal p-values.
Given these deficiencies of single marker tests one can expect that the use
of multi marker models to analyze GWAS will become more and more im-
portant. Multiple linear regression models for quantitative traits and logistic
regression models for case control studies have a long history in genetic as-
sociation studies. To facilitate their use for GWAS there is a strong demand
of two things: A thorough theoretical understanding of different model selec-
tion strategies in high dimensions to find the regression model which includes
important SNPs, as well as the availability of software packages which make
modern statistical methodology applicable to GWAS analysis.
Concerning the theory of high dimensional data analysis the last two
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decades have seen a large number of innovations. One milestone was the
development of LASSO by Tibshirani (1996), which paved the way for a
large number of other new approaches to model selection. A comprehensive
presentation of the theoretical foundations of LASSO and its many extensions
like adaptive LASSO, group lasso or the elastic net can be found in Bu¨hlmann
and van de Geer (2011). In the context of GWAS several algorithms have
been implemented based on LASSO or one of its extensions (Kooperberg
et al., 2010; He and Lin, 2011; Wu et al., 2011) .
From a Bayesian perspective the LASSO is equivalent to model selection
with a double exponential (DE) distribution as shrinkage prior. Among the
first software packages which allowed to perform multi marker analysis of
GWAS was HLASSO (Hoggart et al., 2008), which uses not only DE priors,
but alternatively considers normal exponential Gaussian (NEG) priors. The
NEG distribution is more pointed than DE at 0, resulting in the selection of
potentially smaller models. More recently another version of the Bayesian
LASSO for GWAS analysis was introduced by Li et al. (2011).
The LASSO itself was originally developed for model selection problems
of moderate size, whereas in GWAS one usually is confronted with up to a
million SNPs or more. For such ultra-high dimensional problems Fan et al.
(2008) suggested sure independence screening (SIS) as a convenient way of
dimension reduction. In case of regression models SIS is nothing else but
preselecting a certain number of markers based on marginal tests. After
SIS more refined methods like LASSO or SCAD can be applied to obtain
a model. Using tests conditional on that selected model over all remaining
markers one can apply another SIS step. Iterating SIS and refined model
selection gives the procedure called ISIS.
A startlingly simple but computationally intensive method to improve
the performance of model selection procedures in high dimensions is stabil-
ity selection introduced by Meinshausen and Bu¨hlmann (2010). In stability
selection random subsamples of the data are drawn repeatedly and a given
model selection procedure like LASSO is performed on each of these subsam-
ples. The final model is then obtained by considering those regressors which
have appeared consistently over the repeated samples.
One of the more prominent model selection packages for GWAS is GWAS-
elect by He and Lin (2011), which combines ISIS with stability selection based
on 50 random subsamples, where the refined model selection procedure in
ISIS is LASSO. GWASelect itself uses a prespecified size of the model, but
there exists a ’dynamic’ version d-GWASelect which uses cross-validation to
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fit the LASSO parameter and which determines the number of selected SNPs
using stability selection. Thus in this article GWASelect actually refers to
d-GWASelect, the algorithm which allows to determine the number of inter-
esting SNPs.
An alternative approach to model selection in high dimensions which is
currently gaining popularity is based on information criteria. Among the
large number of SNPs genotyped in GWAS one expects only a moderate
number of SNPs to have a strong effect. In such a sparse setting classi-
cal information criteria like Akaike’s AIC or Schwarz’s Bayesian information
criterion (BIC) have been shown to select too large models (Broman and
Speed, 2002). Consequently Bogdan et al. (2004) introduced a modification
of BIC called mBIC which is designed to control the family wise error rate
(FWER) of selected markers in sparse regression (Bogdan et al., 2008). A
rather similar criterion called EBIC was presented by Chen and Chen (2008),
who showed consistency results for EBIC under sparsity even in case when
the number of markers is growing faster than the number of observations.
Recently Bogdan et al. (2011) coined the notion of asymptotic Bayes
optimality under sparsity (ABOS) which is a stronger property than model
selection consistency. Frommlet et al. (2011) introduced several further mod-
ifications of BIC which have the property of controlling the false discovery
rate (FDR, see Benjamini and Hochberg (1995)), among them mBIC2. It was
shown that the FWER controlling mBIC is ABOS only in case of extreme
sparsity, whereas the FDR controlling criteria are ABOS under a much wider
range of sparsity levels. Further background information on mBIC2 is given
by Frommlet et al. (2012b). In the context of quantitative traits extensive
GWAS simulations based on real SNP data show that mBIC2 is considerably
more powerful to detect causal SNPs than mBIC, while controlling the FDR
at a fixed level.
In this article we will focus on case control studies, where the model selec-
tion task is performed using logistic regression models. Computing maximum
likelihood estimates for each model is much more time consuming than in
case of quantitative traits, and we therefore developed rather involved search
strategies trying to find models which minimize mBIC2. The resulting algo-
rithm is implemented in the software package MOSGWA, and we compare
its performance with single marker tests and with other variable selection
methods, in particular with HLASSO (Hoggart et al., 2008) and GWASe-
lect (He and Lin, 2011). The main reason for this choice is that He and
Lin (2011) already performed a comparison with several other methods for
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GWAS analysis, and HLASSO and GWASelect gave the most convincing
results.
The rest of this paper is organized as follows. In Section 2 we give a
detailed description of the algorithmic aspects of MOSGWA. Section 3 de-
scribes our simulation scenarios for case control studies and compares the
performance of different procedures. Then we reanalyze the GWAS data
from the Wellcome Trust Case-Control Consortium (WTCCC), where Sec-
tion 4 gives a summary and Section 5 a detailed exposition of the results of
this analysis. Finally in Section 6 we discuss our findings and point out how
to extend MOSGWA in the future.
2 Methods
2.1 Selection criterion
Before describing the algorithmic details of MOSGWA we will introduce the
selection criterion mBIC2. Consider a GWAS based on p SNPs and n indi-
viduals. For a given model including kM SNPs our model selection criterion
is of the form
mBIC2 = −2 logL∗M + kM log(np2/4)− 2 log(kM !) . (1)
Each set of SNPs forms a potential modelM , and MOSGWA tries to find that
model which minimizes mBIC2. Here L∗M is the Firth corrected maximum
likelihood, which will be discussed in more detail below.
The penalty of the mBIC2 criterion was introduced in Frommlet et al.
(2011), where its derivation was based on ideas of Abramovich et al. (2006).
In particular mBIC2 is closely related to the Benjamini-Hochberg multiple
testing procedure (Benjamini and Hochberg, 1995), and it controls the false
discovery rate of detected SNPs. In the context of linear regression Frommlet
et al. (2011) have shown certain asymptotic optimality properties of mBIC2.
Roughly speaking it minimizes the misclassification error when both p and
n are large, while the number of regressors of the correct model is relatively
small.
An extensive motivation of mBIC2 can be found in Frommlet et al.
(2012b), where the criterion is applied for linear regression models to an-
alyze GWAS with quantitative traits. In contrast we will focus here on case-
control studies, and just like He and Lin (2011) and Hoggart et al. (2008)
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we make use of logistic regression to model the disease risk of SNPs. To this
end let Yi, i = 1, . . . , n denote the disease status of an individual (Yi = 1
for a case, Yi = 0 for a control), and let xij denote the genotype of SNP
j ∈ {1, . . . , p} for individual i. If a model M includes the SNPs j1, . . . , jk
then the corresponding logistic regression model can be written as
pii := P (Yi = 1|M, θ) =
exp(β0 +
k∑
r=1
βrxijr)
1 + exp(β0 +
k∑
r=1
βrxijr)
, (2)
with the parameter vector θ = (β0, . . . , βk)
T . These k+ 1 parameters can be
routinely estimated by maximizing the corresponding likelihood LM(θ), al-
though occasionally the well known problem of separation may occur, where
some parameter estimates tend towards infinity (Albert and Anderson, 1984).
In classical statistical applications where p  n separation typically arises
only in case of small sample sizes. For GWAS the sample size is usually very
large, but the number of potential regressors is even several orders larger,
which results in many combinations of SNPs for which separation occurs.
Heinze and Schemper (2002) suggested to overcome the problem of separa-
tion using a bias corrected version of logistic regression which was originally
proposed by Firth (1993). The likelihood of the logistic regression model is
multiplied with the corresponding Jeffreys prior, which is just the square root
of the determinant of the Fisher information matrix I(θ). Thus the Firth
corrected maximum likelihood from equation (1) is given by
L∗M = max
θ
LM(θ)
√
|I(θ)| , (3)
and explicit formulas are given for example in Heinze and Schemper (2002).
The Firth-corrected log-likelihood logL∗M includes the penalty term log
√|I(θ)|,
which guarantees that parameter estimates cannot get excessively large. Note
that LASSO based procedures like GWASelect do not run into difficulties
with separation because the L1-penalty yields automatically a shrinkage of
parameters.
2.2 Search strategy
Having defined the model selection criterion (1) the main task is to find
the model which minimizes mBIC2. The resulting problem is an extremely
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challenging mixed integer program, for which one can only attempt to develop
heuristic methods which yield an approximate solution. The search algorithm
of the software package MOSGWA repeatedly makes use of a strategy called
fast stepwise search (FSS).
The aim of FSS is, starting from some initial model, to perform a search
heuristic which finds a model with a smaller value of a given selection crite-
rion. The final call of FSS is performed with the target criterion mBIC2, but
within the search it is valuable to work with less stringent criteria to avoid
getting stuck in local minima corresponding to models which are missing
some of the causal SNPs. Specifically we consider the milder criterion
mBIC60 := −2 logL∗M + kM log(np2/60) .
FSS depends on a pre-specified order of all markers not included in the initial
model. This order is either based on some marginal test statistics, or on some
conditional score tests as described below.
We will formally write the fast stepwise search as a function
M = FSS(Minit, test, criterion) ,
to emphasize that it depends on the initial model, on the specific order of
markers according to test, and on the respective criterion. Depending on
the order of markers two groups are considered: Group G1 consists of the
best m1 SNPs, and group G2 of the best m2 SNPs. Thus G1 ⊂ G2, where
G1 is the set of SNPs along which specifically directed forward steps are
performed (see below), whereas SNPs within G2 might enter the model via
so called exchange steps (see below). The exact choice of the parameters m1
and m2 turns out to be not too important. The default values of MOSGWA
which are also used for simulations are m1 = 350 and m2 = 5000 (as long as
p ≥ 5000).
FSS is based on three algorithmic steps which we call directed forward,
exchange, and backward step. FSS starts with considering the initial model
Minit as the current model. The directed forward step repeatedly tests if en-
hancing the current model with a SNP decreases the criterion, where SNPs
within G1 are considered in the order obtained from the test (therefore di-
rected forward search). The first SNP which improves the current model is
added, and an exchange step follows.
In the exchange step all SNPs in the current model are tested whether
exchanging them with suitable other SNPs decreases the criterion. Suitable
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candidates for exchanging SNP Si are all other SNPs within G2 whose phys-
ical distance to Si on the chromosome is less then d = 50. The idea behind
this strategy is that in the directed search step it might happen that not the
optimal SNP was chosen, but a correlated SNP might further improve the
model. Also after several SNPs have been added to the model it can happen
that exchanging a particular SNP of the model is beneficial. Limiting the
exchange to SNPs close to Si which themselves have reasonably large test
statistic makes this strategy computationally feasible.
The third step of FSS is an extended backward elimination step. A stan-
dard greedy elimination step is performed, and if this does not improve the
model greedy elimination is repeated up to three times to look for better
models. The resulting best model is then starting point for another directed
forward step. Directed forward, exchange, and backward steps are then per-
formed repeatedly till no further improvement of the is criterion achieved.
Now starting with the null model M0 the complete search strategy of
MOSGWA can be specified as follows:
1. M∗ = FSS(M0, Cochran Armitage, mBIC 60)
2. M∗∗ = FSS(M∗, Score Test, mBIC 60)
3. Mfinal = FSS(M∗∗, Score Test, mBIC2)
The general strategy of this algorithm can be motivated as follows. In
the first round markers are preselected based on their marginal (Cochran
Armitage) test statistic. In the second round score tests conditional on the
model M∗ of the first round are performed over all remaining SNPs as de-
scribed in He and Lin (2011). Score tests have the benefit of being computa-
tionally much less expensive than likelihood ratio test, and therefore provide
a fast way to preselect markers which might be of importance additional to
markers within M∗.
The first two rounds are performed with the milder criterion mBIC 60,
which is expected to yield models which are too large. In fact when models
are getting too large then the value of d from the exchange step is reduced
to guarantee reasonable runtime. As mentioned previously the benefit of
first working with mBIC 60 is that one reduces the chances of missing out
on important SNPs due to local minima. Only in the final round FSS is
performed with the target criterion mBIC2, and should then yield a model
for which the type I error rate is controlled in terms of FDR.
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3 Simulation Studies
3.1 Global null hypothesis
Our first set of simulations is concerned with controlling the type I error
under the global null hypothesis. Simulations are based on real SNP data
from n = 4077 individuals from the POPRES sample (Nelson et al, 2008),
which are included in the POPRES Genotypes QC2 dataset. Individuals
are randomly allocated as cases and as controls with equal probability; then
MOSGWA, HLASSO and GWASelect are applied to evaluate their ability
to control the type I error rate. The random allocation was repeated 200
times, and Table 1 presents the average number of observed false positives
to estimate the per-family error rate. A graphic illustration is provided in
Figure 3.1.
Figure 1: Illustration of the simulation results under the total null corre-
sponding to Table 1. The average number of false positives for MOSGWA
is compared with HLASSO (left panel) and with GWASelect (right panel),
for which false positives were clustered. Simulations were performed for four
different numbers of chromosomes, resulting in different numbers of SNPs
plotted on the x-axis.
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Table 1: Mean number of false positives under the global null hypothesis. p
refers to the total number of SNPs. The methods analyzed were MOSGWA
(MOS), HLASSO with three different choices of the parameter α, GWASelect
with three different choices of the stable-selection-threshold ξ, and single
marker tests (SM) with Benjamini Hochberg procedure at level α = 0.05.
p MOS HLASSO (α) GWASelect (ξ) SM
.3/p .2/p .1/p .1 .2 .3
27520 0.16 0.22 0.12 0.03 51.1 9.34 2.34 0.04
56629 0.13 0.13 0.07 0.03 43.34 6.73 1.51 0.04
103348 0.13 0.18 0.11 0.04 36.64 4.90 1.06 0.04
149478 0.13 0.16 0.05 0.03 32.22 4.19 0.79 0.06
To study the influence of the number of SNPs we performed four differ-
ent simulations using SNPs only from chromosome 1, from the first two, the
first four and the first six chromosomes, respectively. The resulting num-
ber of SNPs, p, for these four scenarios is given in the first column of Table
1. GWASelect and single marker tests tend to report a large number of
correlated SNPs, and thus for these two procedures the number of false pos-
itives was obtained by counting clusters of neighboring SNPs as described
by He and Lin (2011), where clustering was performed with the algorithm of
Frommlet (2010). For HLASSO and MOSGWA no such clustering is nec-
essary, because these algorithms tend to select only one representative for a
genomic region anyway.
Table 1 illustrates that MOSGWA controls the type I error under the
total null hypothesis irrespective of the number of SNPs. For MOSGWA
no parameter needs to be tuned, whereas the latest version of HLASSO
allows to choose a parameter α which corresponds to an uncorrected nominal
significance level. We consider three Bonferroni-like choices of the form α ∈
{0.3/p, 0.2/p, 0.1/p}. The results from Table 1 indicate that the type I error
tends to remain below the nominal level, which is not too surprising given the
positive correlations between neighboring SNPs due to linkage disequilibrium.
Type I error rates for α = 0.3/p are closest to those from MOSGWA, and
therefore in Section 3.2 HLASSO will be used with this parameter setting.
The size of the model selected by GWASelect depends on the stable-
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selection-threshold ξ. He and Lin (2011) recommend a choice of ξ between
0.1 and 0.2, but the results from Table 1 show that for these parameter
settings GWASelect completely fails to control the type I error rate under
the global null. We therefore considered additionally ξ = 0.3, for which the
per-family error rate is controlled at least to some extent. Interestingly the
type I error from GWASelect decreases when the number of SNPs increases.
The last column of Table 1 provides the results of single marker tests per-
formed with PLINK (Purcell et al., 2007). We considered logistic regression
models for each marker including the first four principle components of all
SNP genotypes as covariates to account for population structure. This kind
of adjustment is in principle not necessary when simulating under the total
null hypothesis, but it becomes important for the simulations of Section 3.2.
We applied the Benjamini Hochberg procedure to account for multiple test-
ing, and we can see that under the total null hypothesis the single marker
tests control the type I error rate pretty much at the nominal level α = 0.05.
3.2 Complex trait
The second set of simulations is concerned with the power to detect causal
SNPs. To this end we consider again the 149478 SNPs from Chromosome
1-6 for the 4077 individuals from the POPRES sample. Simulations are
performed for three scenarios, which include 6, 12, and 24 causal SNPs,
respectively. All causal SNPs are common (MAF > 0.3), equally distributed
over the six chromosomes, and with pairwise correlation ρ < 0.1 for each
pair. Disease risk was computed for each individual according to equation
(2), based on which for each scenario 200 case-control data sets were sampled.
Effect sizes βj were ranging in the interval [0.2, 0.28], yielding causal SNPs
with intermediate power. The coefficient of the intercept β0 was chosen such
that the number of cases and controls in each simulation run was more or
less identical.
Before analyzing the data in each scenario half of the causal SNPs were
removed, mimicking the situation where SNPs associated with a trait are not
causal themselves, but only in linkage disequilibrium with the cause. SNPs
to be removed were selected in such a way that there actually were SNPs in
linkage disequilibrium, to make it possible for these signals to be detected.
The simulated data were then analyzed with MOSGWA, HLASSO (using
parameter α = 0.3/p), GWASelect using parameters ξ ∈ {0.1, 0.2, 0.3} and
with single marker tests (as previously including the four leading principal
11
Figure 2: Simulation results under an alternative with k = 6 causal SNPs.
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components in logistic regression models and applying Benjamini Hochberg
procedure at nominal level α = 0.05).
Table 2 and Figures 2, 3 and 4 summarize the corresponding results in
terms of estimated power (which is just the average number of correctly
detected signals divided by the total number of causal SNPs), the average
number of false positives, the average number of misclassifications (that is
false positive plus missed causal SNPs) and the estimated false discovery
rate.
A crucial point in computing all these statistics is the definition of true
positives and false positives. Of course we know the SNPs which we used to
simulate the data, which we will call causal SNPs or correct SNPs. Now there
might be several SNPs in close linkage disequilibrium with a causal SNP. Do
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Figure 3: Simulation results under an alternative with k = 12 causal SNPs.
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we count a detected SNP which is strongly correlated with the correct SNP
as true positive or as false positive? Furthermore half of the causal SNPs
under which we simulated were selected to be removed before analyzing the
data. To get reasonable results we thus actually have to count detections
which are strongly correlated with a causal SNP as true positives.
Just like Hoggart et al. (2008) and He and Lin (2011) we use threshold
values C on the correlation between causal SNPs and any detected SNP to
determine whether a detected SNP is a true positive. If several detected
SNPs are closely correlated to one causal SNP we count all of them as one
true positive. As described in the main manuscript we have additionally
clustered the false positives of GWASelect and of the single marker analysis.
This was performed with the algorithm described by Frommlet (2010) which
13
Figure 4: Simulation results under an alternative with k = 24 causal SNPs.
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computes so called C-clusters, that is clusters of SNPs where it is guaranteed
that within each cluster all SNPs have pairwise correlation larger than C.
We used for clustering and for determining true positives always the same
constant C. Counting the number of clusters rather than the total number
of false positives works in favor of the performance of GWASelect and single
marker tests. Both for MOSGWA and HLASSO such clustering appears to
be unnecessary, because for a genomic region of closely related SNPs usually
these procedures select only one representative.
In Figures 2, 3 and 4 we illustrate the dependence of the different statistics
on the threshold values C for correlations which specify true positives via
|R| > C. Results were computed for C ∈ {0.2, 0.3, 0.4, 0.55, 0.7, 0.9}. One
can see that within the range of 0.2 ≤ C ≤ 0.55 the dependence on the
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threshold is relatively minor for all methods. In general the choice of C has
the biggest impact on the results of single marker tests. For those the number
of false positives grows much faster than for the other methods, because the
number of false positive clusters increases with stricter clustering threshold
C. Table 2 specifically reports the results for a threshold C = 0.3.
For all three scenarios MOSGWA has the lowest number of misclassifi-
Table 2: Summary of simulation results for complex traits. The average
over 200 simulation runs is reported for the number of detected associations
(Size), the estimated power, the number of false positive detections (FP),
the estimated false discovery rate (FDR) and the average number of misclas-
sifications (Mis). GWASelect performed with parameters ξ ∈ {0.1, 0.2, 0.3}
is abbreviated as GS ξ, MOSGWA as MOS , HLASSO as HL, and single
marker tests as SM.
MOS HL GS 0.1 GS 0.2 GS 0.3 SM
Scenario 1: (k = 6)
Size 5.32 5.94 23.36 5.87 3.03 4.40
Power 0.69 0.67 0.74 0.57 0.41 0.59
FP 1.19 1.90 18.90 2.43 0.57 0.85
FDR 0.19 0.27 0.77 0.35 0.16 0.14
Mis 3.07 3.86 20.44 5.00 4.12 3.31
Scenario 2: (k = 12)
Size 9.80 8.19 23.35 7.31 3.77 9.17
Power 0.68 0.59 0.65 0.45 0.28 0.63
FP 1.65 1.16 15.49 1.88 0.37 1.65
FDR 0.15 0.17 0.63 0.23 0.08 0.16
Mis 5.49 6.13 19.63 8.46 8.97 6.13
Scenario 3: (k = 24)
Size 18.03 13.71 31.29 11.43 6.43 17.76
Power 0.65 0.52 0.57 0.37 0.24 0.62
FP 2.39 1.27 17.63 2.49 0.67 2.99
FDR 0.13 0.09 0.54 0.20 0.09 0.16
Mis 10.75 12.83 27.97 17.56 18.91 12.22
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cations, which is in accordance with the theoretical results from Frommlet
et al. (2011). Of particular interest is the comparison between MOSGWA
and HLASSO. For k = 6 MOSGWA has slightly larger power and lower
Type I error. For k = 12 and specifically for k = 24 MOSGWA has much
larger power than HLASSO, but also larger Type I error. When the num-
ber of causal SNPs is increasing then HLASSO is getting more conservative
in comparison with MOSGWA, which is in accordance with the way both
algorithms are designed. HLASSO tries to control the FWER at a certain
level, whereas MOSGWA tries to control the FDR. According to the theory
of Bogdan et al. (2011) and Frommlet and Bogdan (2013), when aiming at
a minimal number of misclassifications in a sparse setting it is preferable to
control FDR rather than FWER.
Concerning GWASelect just like under the total null hypothesis the choice
of ξ = 0.1 gives way too large models. The choice of ξ = 0.2 works slightly
better in terms of controlling the Type I error, but is less powerful than
MOSGWA and HLASSO. Given the simulation results under the total null
hypothesis one actually should use the setting ξ = 0.3, but then GWASelect
is no longer competitive at all in terms of power.
The single marker tests are performing surprisingly well, and the disad-
vantage compared to the model selection approaches is much less than it was
observed by Frommlet et al. (2012b) for quantitative traits. However, we
believe that this is mainly due to the fact that we have added the first four
principle components of SNP genotypes. Although we did not specifically
simulate scenarios where population structure would play a major role in it-
self, when testing a specific SNP the principle components in the model help
to adjust for the net effect of all the other causal SNPs. Without adding prin-
ciple components the performance of the single marker tests was extremely
poor. Also note that for MOSGWA we did not specifically take any measures
to take into account population structure. Still it is much more powerful than
single marker tests in all three scenarios, while at the same time controlling
FDR at a comparable level.
4 Real Data
The Wellcome Trust data for genome-wide association studies on seven differ-
ent diseases (WTCCC, 2007) have become benchmark data sets for compar-
ing different algorithms to analyze GWAS. For each disease approximately
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2000 cases were compared with a common set of approximately 3000 con-
trols. More than half a million SNPs were genotyped with the Affymetrix
GeneChip 500K, from which less than 400,000 passed quality control. The
original analysis from WTCCC was mainly based on single marker tests and
identified 24 significant SNPs for the seven diseases.
The analysis of He and Lin (2011) using GWASelect resulted in 60 dis-
tinct loci. Unfortunately we were not able to completely reproduce their
results, which has several reasons. First of all He and Lin (2011) did not
fully document their preprocessing of data for quality control, and model
selection analysis of GWAS data is extremely sensitive with respect to the
set of SNPs being studied. Furthermore they seem to have used not always
the same parameter ξ for d-GWASelect, but adapted this for different dis-
eases. We provide next a detailed description of the preprocessing steps we
performed, and how they differ from He and Lin (2011).
4.1 Data preprocessing of WTCCC data
We reanalyzed bipolar disorder (BD), coronary heart disease (CAD), hyper-
tension (HT), Crohn’s disease (IBD), rheumatoid athritis (RA), type 1 dia-
betes (T1D) and type 2 diabetes (T2D). Like in the original article WTCCC
(2007) all diseases respectively are compared with the same control group of
3000 individuals. In the following filenames we will denote by <DIS> any of
the seven abbreviations for diseases given above.
Starting from the already imputed WTCCC data sets we removed in-
dividuals for each disease and for the control group according to the files
exclusion-list-05-02-2007-<DIS>.txt and exclusion-list-snps-26 04 2007.txt.
After merging cases with controls we removed SNPs with a minimal al-
lelic frequency smaller than 0.01. Furthermore we tested for Hardy Weinberg
equilibrium and SNPs with p-values smaller than 0.0001 were also removed.
Finally we only considered SNPs for which the genotype calling algorithm
from the WTCCC confirmed good clustering, where we took that informa-
tion from the file WTCCC summary data/7 Diseases/<DIS>/basic/snptest <DIS> <CHR>.txt,
where <CHR> is the chromosome number ranging from 1 to 22. According
to private correspondence He and Lin (2011) had used for similar purposes
the file wtccc <DIS> basic chr <CHR>.xml, which must have differed from
the file we have used, but is no longer available from WTCCC. In summary,
after preprocessing we will have ended up with a different set of SNPs than
He and Lin (2011), and according to e-mail correspondence with He it is no
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Table 3: Number of detected SNPs which are associated to the following
seven diseases from WTCCC: Bipolar disorder (BD), coronary artery dis-
ease (CAD), hypertension (HT), Crohn’s disease (IBD), rheumatoid arthri-
tis (RA), type 1 diabetes (T1D) and type 2 diabetes (T2D). WTCCC refers
to the regions reported by the original publication (WTCCC, 2007) in their
Table 3, abbreviations for the other algorithms are just like in Table 2. In
brackets we give the number of DNA regions which are covered by the de-
tected SNPs (see Section 5 below for details). The whole HLA region on
chromosome 6 is counted as only one region.
Disease WTCCC MOS HL GS 0.3 GS 0.2 GS 0.1
BD (1) 1 (1) 1 (1) 1 (1) 9 (9) 43 (39)
CAD (1) 2 (2) 3 (2) 3 (2) 4 (2) 29 (21)
HT (0) 1 (1) 1 (1) 1 (1) 4 (4) 29 (26)
IBD (9) 17 (16) 12 (8) 12 (5) 15 (6) 32 (19)
RA (3) 11 (5) 12(2) 1(1) 1(1) 13 (2)
T1D (7) 25 (11) 22 (4) 12 (2) 20 (2) 33 (2)
T2D (3) 2 (2) 3 (2) 4 (2) 8 (4) 28 (19)
longer possible to reconstruct which set of SNPs they had used for their own
analysis. Not starting from the same set of SNPs could explain why we were
not able to completely reproduce the results reported in He and Lin (2011).
4.2 Summary of results
Like in the simulation study HLASSO was applied with parameter α = 0.3,
and for GWASelect we present the results again for ξ ∈ {0.1, 0.2, 0.3}, in spite
of the fact that we have seen that only ξ = 0.3 controls the type I error rate
under the total null hypothesis. Table 3 gives for each disease the number of
detected SNPs (and associated regions) obtained from the original WTCCC
analysis, MOSGWA, HLASSO, and GWASelect. The full information on the
detected SNPs is provided in Section 5.
The first observation is that GWASelect with parameter ξ = 0.1 is se-
lecting in 6 out of 7 diseases a much larger number of SNPs than the other
methods. Given the results from the simulation study of Section 3 we are
forced to conclude that most of those SNPs might be false positives, and we
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will not give the detailed results for GS 0.1 in Section 5 except for rheumatoid
arthritis, where interestingly GS 0.1 gives quite similar results to MOSGWA
and HLASSO (for a detailed explanation see Section 5). For Crohn’s disease
and Type I diabetes the results for ξ = 0.2 are relatively close to MOSGWA
and HLASSO, whereas for all other diseases ξ = 0.3 might be the best choice
for GWASelect. The general conclusion is that the results of GWASelect
heavily depend on the choice of ξ, and it is not really possible to know in
advance which choice gives reliable results.
The comparison between MOSGWA and HLASSO is quite interesting.
For the four diseases for which only a small number of SNPs was detected
(BD, CAD, HT, T2D) MOSGWA finds exactly the same regions as HLASSO,
though in two cases one SNP less. Similarly MOSGWA has a tendency to
select less representatives of a region than HLASSO for the remaining more
complex traits. This might have to do with the fact that the coefficient
estimates of MOSGWA suffer from even less shrinkage than the estimates
from HLASSO. Hoggart et al. (2008) thoroughly discussed the fact that due
to shrinkage regressors which enter the model explain less than they would
without shrinkage, which results in a higher chance of including further corre-
lated SNPs in the model. This was the main reason why HLASSO works with
the NEG prior, which results in less shrinkage than the double exponential
prior which corresponds to LASSO.
Now especially for complex traits MOSGWA tends to select more regions
of association than HLASSO. This goes along with the fact that HLASSO
is designed to control the FWER, whereas MOSGWA controls the FDR. In
case of complex traits MOSGWA is therefore bound to find more SNPs than
HLASSO, whereas if there are only few signals both methods behave very
similarly.
Looking more closely into the results for IBD, RA and T1D, the first
observation is that MOSGWA detects SNPs within all regions which were
reported as significant by the WTCCC (2007) according to their standard
analysis. The same is not true for HLASSO, which misses out on one region
on chromosome 10 for RA, and on another region on chromosome 16 for T1D.
On the other hand MOSGWA finds exclusively 7 SNPs for IBD, 4 SNPs for
RA, and 6 SNPs for T1D, respectively. These SNPs are highlighted in yellow
in the corresponding tables of Section 5. For RA and T1D all these extra
SNPs are lying outside of the HLA regions. We are not particularly inter-
ested here in genetic loci within the HLA region, which have been intensively
studied now for several decades, but specifically on SNPs outside the HLA.
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In the next Section we will provide a thorough discussion on the potential
relevance of the SNPs which were exclusively found by MOSGWA.
5 WTCCC Results in detail
In this section of the appendix we provide detailed results on the SNPs de-
tected by the different methods of analysis for the seven diseases for which
GWAS data are available from WTCCC (2007). For all tables the first
column gives the reference SNP ID number from dbSNP, followed by the
chromosome (Chr) and the position (Pos). The column Gene contains infor-
mation about the closest lying gene according to the databases dbSNP and
ImmunoBase:
• dbSNP: http://www.ncbi.nlm.nih.gov/SNP/
• ImmunoBase: http://www.immunobase.org/
The final columns have bullets whenever a SNP was detected by MOS-
GWA (M), Hlasso (HL), GWASelect with parameter ξ = 0.3 (G3) or ξ = 0.2
(G2). According to the simulation results from Section 3 we believe that
the large number of additional SNPs detected by GWASelect with ξ = 0.1
(G1) will include mainly false positives. Therefore we do not present detailed
results for G1, with the exception of rheumatoid arthritis which has a rather
particular genetic constellation. If many neighboring SNPs are reported by
different methods we consider such groups of SNPs as genetic regions, and we
label such groups in the tables using background colors. The crosses in the
last column (W) indicate regions which were reported in WTCCC (2007).
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5.1 Bipolar disorder (BD)
dbSNP Chr Pos Gene M HL G3 G2
rs2953145 2 241515596 RNPEPL1 •
rs4627791 3 32347824 CMTM8 •
rs715891 5 145986083 PPP2R2B •
rs10993706 9 93602967 SYK •
rs11622475 14 104509076 TDRD9 •
rs2576561 16 55470974 MMP2 •
rs7243929 18 8455102 PTPRM •
rs12980129 19 22908911 ZNF99 •
rs2837588 21 41748059 DSCAM • • • •
SNP rs2837588, which is an intron of DSCAM, was found by all methods,
though it was not reported in WTCCC (2007). On the other hand the
only SNP reported by WTCCC, rs4202459, was not detected by any of the
algorithms we analyzed here. This can be quite easily explained because all
algorithms we study here are based on models incorporating linear trends,
and the trend p-value of rs4202459 is quite large (2.19 E-04 according to the
WTCCC manuscript). That rs2837588 was not reported by WTCCC might
have to do with the large number of missing values for this SNP. Results
reported in WTCCC (2007) are not based on imputed data, and imputation
changes the marginal p-value for this SNP considerably. More recent research
indicates that there actually might be a connection between bipolar disorder
and DSCAM (Amano et al., 2008), although in general according to a recent
large GWAS (McPherson et al., 2013) it appears to be extremely difficult to
identify robust and replicable genetic causes for psychiatric disorders. Thus
all the other SNPs reported by G2 have a good chance to be false positives.
5.2 Coronary artery disease (CAD)
dbSNP Chr Pos Gene M HL G3 G2 W
rs906766 3 150811294 MED12L • • • •
rs10965219 9 22053687 CDKN2B-AS • • • x
rs6475606 9 22081850 CDKN2B-AS • x
rs1333049 9 22125503 DMRTA1 • • • • x
Here the original WTCCC study reported only one region, whereas all
methods studied here detect two regions. Note that MOSGWA selects only
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one representative of the region reported by WTCCC, whereas HLASSO
reports two representatives. This is a pattern we will see again several times,
for example in type II diabetes. A possible explanation why HLASSO prefers
to choose more representatives of a region than MOSGWA might be that
MOSGWA is based on model selection criteria which impose less shrinkage
on the coefficients than HLASSO does. The effect of shrinkage on the number
of selected correlated SNPs is thoroughly described by Hoggart et al. (2008).
5.3 Hypertension (HT)
dbSNP Chr Pos Gene M HL G3 G2
rs7961152 12 24981611 BCAT1 •
rs921535 15 74111343 TBC1D21 •
rs16945811 17 1294614 YWHAE • • • •
rs1022684 20 18487506 SEC23B •
The original WTCCC study did not report any SNP associated with
hypertension, whereas all methods studied here report rs16945811 on chro-
mosome 17. The reason for this is again that we work with imputed data,
for which the marginal p-value of this SNP is considerably smaller than for
the original unimputed data. The other SNPs reported by G2 are again very
likely to be false positives.
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5.4 Crohns disease (IBD)
dbSNP Chr Pos Gene M HL G3 G2 W
rs17375018 1 67655147 IL23R CD25 • x
rs11805303 1 67675516 IL23R • • • • x
rs10489629 1 67688349 IL23R • • • x
rs41396545 1 67689608 IL23R • • x
rs12119179 1 67747415 IL12RB2 • • x
rs12035082 1 172898377 TNFSF18 •
rs10210302 2 234158839 ATG16L1 • • • • x
rs11718165 3 49696797 BSN • x
rs7726744 5 40343276 PTGER4 • x
rs12658567 5 40391932 PTGER4 • x
rs16869934 5 40397352 PTGER4 • x
rs17234657 5 40401509 PTGER4 • • • • x
rs9292777 5 40437948 PTGER4 • • • x
rs11957215 5 40445681 PTGER4 • • x
rs1505992 5 40498577 PTGER4 • • x
rs11957134 5 150230950 ZNF300 • x
rs1000113 5 150240076 ZNF300 • x
rs9405639 6 3419149 SLC22A23 •
rs6908425 6 20728731 CDKAL1 •
rs4263839 9 117566440 TNFSF15 •
rs10761659 10 64445564 ZNF365 • • • x
rs10883365 10 101287764 NKX2-3 • x
rs10883371 10 101292455 NKX2-3 • x
rs11627513 14 97539171 LOC100129345 •
rs2076756 16 50756881 NOD2 • • • • x
rs7342715 16 50787483 CYLD • • • x
rs2542151 18 12779947 PTPN2 • • • • x
rs41526044 20 18800670 SLC24A3 •
rs2836753 21 40291187 PSMG1 •
This is the first disease for which model selection approaches become re-
ally interesting, because the trait appears to be a complex one. Note that
HLASSO finds one region less (on chromosome 3) than originally reported in
WTCCC (2007), whereas MOSGWA finds all regions reported by WTCCC
plus seven additional ones which are highlighted in yellow in the table above.
At least five of those have been mentioned meanwhile in the literature on
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Crohn’s disease, which means that MOSGWA would have detected a num-
ber of SNPs associated with Crohn’s disease which were later confirmed by
independent studies.
Let’s look at those SNPs in detail. The first SNP rs12035082 is close to
rs12037606 which was actually reported in WTCCC (2007) among the SNPs
which showed moderate evidence of association, and was later confirmed to
be associated with CD by McPherson et al. (2009). Similarly rs6908425 was
reported as being moderately associated in WTCCC (2007), and could later
be confirmed in an independent study (Barrett et al., 2008). rs4263839 was
not reported by WTCCC, but it was among the list of confirmed SNPs given
by Barrett et al. (2008). Furthermore it has later been shown to be associated
with irritable bowel syndrome (Zucchelli et al., 2011). rs2836753 is in close
linkage disequilibrium with rs2836754, which was related to Crohn’s disease
in Parkes et al. (2009).
rs6908425 is an intron from the CDKALI gene on chromosome 6 and
has been confirmed to be associated to Crohn’s disease (see for example the
evidence provided in snpedia for this SNP. rs9405639 on chromosome 9 lies
within the intron of SLC22A23 gene, which is also well known to be related
to Crohn’s disease, see for example
http://www.immunobase.org/page/Overview/display/gene id/63027.
The only two SNPs detected by MOSGWA based on the WTCCC data
which have not been confirmed in the literature are rs11627513 and rs41526044.
rs11627513 is relatively close to the IL23R which is known to be associated
with Crohn’s disease
(see http://www.immunobase.org/page/Overview/display/gene id/149233).
and it was mentioned in Hoffman et al. (2013) as a potentially associated
gene. Up to our knowledge only for rs11627513 nothing is known, and this
might well be a false positive. Remember that MOSGWA is designed to con-
trol the FDR approximately at a level of 10%, and thus one would actually
expect 2 false positive SNPs within this model.
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5.5 Rheumatoid arthritis (RA)
dbSNP Chr Pos Gene M HL G3 G2 G1 W
rs6679677 1 114303808 RSBN1 • • • x
rs3132671 6 30178287 TRIM26 • • x
rs3099844 6 31448976 MICB • x
rs707974 6 31629499 BAT4 • • x
rs2075800 6 31777946 HSPA1L • x
rs17421624 6 32066177 TNXB • x
rs3134926 6 32200147 NOTCH4 • • x
rs9267954 6 32213052 NOTCH4 • x
rs910049 6 32315727 C6orf10 • x
rs9268418 6 32343686 C6orf10 • • x
rs9268560 6 32389512 HLA-DRA • • x
rs9268853 6 32429643 HLA-DRB5 • x
rs9268858 6 32429758 HLA-DRB5 • x
rs9272219 6 32602269 HLA-DQA1 • x
rs2856688 6 32654640 HLA-DQB1 • x
rs7775228 6 32658079 HLA-DQB1 • • x
rs6457617 6 32663851 HLA-DQB1 • • • • x
rs9275418 6 32670244 HLA-DQB1 • • • x
rs9275572 6 32678999 HLA-DQA2 • x
rs3128963 6 33055780 HLA-DPB1 • • x
rs12536071 7 42428460 GLI3 •
rs12531052 7 42428629 GLI3 •
rs2104286 10 6099045 IL2RA •
rs1945076 11 106382378 GUCY1A2 •
All SNPs detected on chromosome 6 belong to the so called HLA region
which has been well known for a long time to be associated with rheumatoid
arthritis (Deighton et al., 1989). According to Chatzikyriakidou et al. (2013)
HLA genes explain only approximately one-third of the genetic liability of the
disease, and a great amount of research has been performed to understand
genetic causes beyond HLA. For the rheumatoid arthritis data GWASelect
performs very poor, for parameters ξ = 0.3 and ξ = 0.2 only one SNP in
the HLA region is reported. This is quite easy to understand given the
way GWASelect works. In the HLA region there are many highly correlated
SNPs, and during the stability selection procedure it is very likely that for
different samples different representatives of a cluster of SNPs are chosen.
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Therefore only for the lowest threshold ξ = 0.1 GWASelect gives results
which are more in line with the other methods. This is the reason why He
and Lin (2011) clustered the HLA region before analyzing that data set,
but that appears to be quite an extra effort for the user when applying
GWASelect. Neither MOSGWA nor HLASSO did have particular problems
with including the HLA region in the analysis, and both find apart from
SNPs in the HLA region also rs6679677 on chromosome 1. This SNP was
already reported in WTCCC (2007), but according to a recent meta-analysis
by Chatzikyriakidou et al. (2013) this region actually could not be confirmed
to be associated with rheumatoid arthritis.
Four SNPs were then only detected by MOSGWA which are highlighted
in the table above in yellow. These detections appear to be rather interesting.
rs2104286 lies in the intron of the IL-2RA gene, and according to Chatzikyri-
akidou et al. (2013) this SNP is definitely associated with rheumatoid arthri-
tis. It was reported in WTCCC (2007) after pooling data from RA and T1D,
but it was not detected when using the standard analysis for data only from
the RA population. rs1946518 from chromosome 11 is not mentioned in the
meta-analysis, but one finds in the literature that the GUCY1A2 gene is
down regulated in case of rheumatoid arthritis (Del Rey et al., 2010). This
indicates that there might be a functional connection between this region
and RA.
Finally there remain two SNPs from the GLI3 gene on chromosome 7.
Again nothing is said about those in the meta-analysis of Chatzikyriakidou
et al. (2013). However, the GLI3 gene is known to be a member of the
Hedgehog signaling pathway which is important for the proper development
of embryos, and is also known to play an important role in adults (Villavicen-
cio et al., 2000). rs12536071 has a relatively small marginal p-value (5.2E-06),
whereas the neighboring SNP rs12531052 has a rather large marginal p-values
(0.167944 ). It is pretty unusual for MOSGWA to select two SNPs which
are located so close to each other, which might indicate that actually some
epistatic effect could be involved here.
5.6 Type I diabetes (T1D)
Similarly to rheumatoid arthritis also for type I diabetes the HLA region plays
an important role, where according to Bradfield et al. (2011) approximately
half of the genetic risk for T1D is found in HLA region. GWASelect is
handling the situation here slightly better than in case of RA, but still it
26
dbSNP Chr Pos Gene M HL G3 G2 W
rs6679677 1 114303808 RSBN1 • • • • x
rs1025039 5 35901857 CAPSL •
rs9261376 6 29.8-30.2MB unknown • x
rs16894900 6 29395499 OR11A1 • x
rs6906897 6 29415636 OR12D3 • x
rs17508548 6 29563067 GABBR1 • x
rs9258205 6 29703823 LOC285830 • x
rs1615251 6 29745761 HCG4 • x
rs3130531 6 31206616 HLA-C • • x
rs4959068 6 31343844 MICA • x
rs2248462 6 31446796 MICB • x
rs3131631 6 31484683 MICB • • • x
rs9348876 6 31575276 NCR3 • x
rs376510 6 31688200 LY6G6C • x
rs707915 6 31710968 MSH5 • x
rs2763979 6 31794592 HSPA1B • • • x
rs492899 6 31933518 SKIV2L • • x
rs408359 6 32141883 AGPAT1 • x
rs3129900 6 32305979 C6orf10 • x
rs3129933 6 32336161 C6orf10 • • • • x
rs3129934 6 32336187 C6orf10 • • • x
rs9391858 6 32341398 C6orf10 • x
rs2894254 6 32345689 C6orf10 • x
rs3135377 6 32385399 HLA-DRA • • x
rs3135393 6 32408842 HLA-DRA • x
rs9268877 6 32431147 HLA-DRB5 • • • x
rs4530903 6 32581889 HLA-DQA1 • • • x
rs9272346 6 32604372 HLA-DQA1 • x
rs9272723 6 32609427 HLA-DQA1 • • • x
s9273363 6 32626272 HLA-DQB1 • • • • x
rs35120848 6 32670495 HLA-DQB1 • • • x
rs2227127 6 32711782 HLA-DQA2 • • • x
rs2071474 6 32782582 HLA-DOB • x
rs241427 6 32804414 TAP2 • • x
rs3101942 6 32870057 LOC100294145 • • • x
rs3116985 6 33100590 HLA-DPB2 • x
rs7382464 6 33150268 COL11A2 • x
rs6928921 6 85062826 KIAA1009 •
rs2666236 10 33418872 NRP1 •
rs11171739 12 56470625 ERBB3 • • x
rs17696736 12 112486818 NAA25 • • x
rs7157296 14 50566882 C14orf138 •
rs12924729 16 11187783 CLEC16A • x
rs2542151 18 12779947 PTPN2 •
rs41384747 18 16913046 unknown •
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detects apart from HLA SNPs only rs6679677 on chromosome 1, which is also
reported by all other methods. In the original work (WTCCC, 2007) three
more SNPs are found to have strong association with T1D. All of those were
found by MOSGWA, whereas HLASSO missed rs12924729 on chromosome
16. MOSGWA reported 6 additional SNPs which are again highlighted in
yellow.
rs41384747 on chromosome 18 is close to rs2542151 which was already
listed among SNPs with moderate association in WTCCC (2007). The region
was later confirmed in replication studies (see Barrett et al. (2009)), and also
includes SNP rs478582 listed in Bradfield et al. (2011). Similarly the region
on chromosome 5 in which rs1025039 lies has been known as a susceptibility
locus for T1D. In the same region lies rs6897932 which is associated with T1D
according to Barrett et al. (2009). Perhaps the most comprehensive source
today for human Type 1 Diabetes loci is the database http://t1dbase.org.
There one can find that the region on chromosome 18 is listed as being
associated with T1D, but not the region on chromosome 5.
The closest region to rs6928921 on chromosome 6 which is documented in
t1dbase is 6q15 with the BACH2 gene, which is 5 MB upstream. Nothing is
known about any influence of KIAA1009 on T1D. There is more indication
that rs2666236 on chromosome 10 might be associated with T1D, as it is
known that the corresponding gene NRP1 is associated with T1D (Hasan
et al., 2010). However, again the region of rs2666236 is not listed in t1dbase.
Nothing is known about the other SNPs rs7157296 on chromosome 14 and
rs41384747 on chromosome 18, and they might thus be false positives. Note
that MOSGWA is tuned to have an FDR of approximately 10%, and thus 2
or 3 false positive SNPs are to be expected in this model.
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5.7 Type II diabetes (T2D)
dbSNP Chr Pos Gene M HL G3 G2 W
rs9465871 6 20717255 CDKAL1 • x
rs7917983 10 114732882 TCF7L2 • x
rs7901275 10 114732906 TCF7L2 • x
rs4074720 10 114748497 TCF7L2 • x
rs7901695 10 114754088 TCF7L2 • • • x
rs4506565 10 114756041 TCF7L2 • • • x
rs7077039 10 114789077 TCF7L2 • • x
rs7961581 12 71663102 TSPAN8 •
rs7193144 16 53810686 FTO • x
rs8050136 16 53816275 FTO • • • x
With type 2 diabetes a smaller number of genetic regions seems to be
associated than with the previous three diseases. Thus the model selection
approach appears to have less benefits compared with the standard analy-
sis. MOSGWA does not report rs9465871 on chromosome 6, but looking at
the original analysis from WTCCC (2007) this SNP has a trend p-value of
1.02 E-6, which is not significant after any standard correction for multiple
testing. Apart from that all algorithms report SNPs within the two main
regions on chromosome 10 and 16, where MOSGWA chooses again only one
representative for gene TCF7L2 on chromosome 10.
6 Discussion
We have introduced MOSGWA, a new algorithm for GWAS analysis us-
ing the FDR controlling model selection criterion mBIC2. We compared its
performance with two existing variable selection methods, GWASelect and
HLASSO. The first observation was that both MOSGWA and HLASSO are
controlling the Type I error rate under the global null hypothesis, whereas
GWASelect does not manage to do that when using the recommended pa-
rameter setting ξ ∈ [0.1, 0.2]. He and Lin (2011) only presented simulation
results for scenarios including 10 causal SNPs, for which they reported rel-
atively low FDR. In accordance we observed that GWASelect tends to have
lower type I error rate when the true model underlying simulations includes
more causal SNPs. However, a method which selects very large models even
when we know that there is no genetic cause for the disease status appears
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to be rather problematic. When increasing the selection threshold to ξ = 0.3
then GWASelect more or less controls the type I error under the global null,
but then it is no longer competitive in terms of power to detect causal SNPs.
One advantage of MOSGWA is that there is actually no parameter tuning
necessary at all, because the selection criterion is fixed.
Apart from GWASelect and HLASSO we have also compared the per-
formance of the original LASSO as implemented in glmnet Friedman et al.
(2010), although we decided not to present the corresponding results in this
manuscript. LASSO previously has been shown to perform well in GWAS
in terms of prediction Kooperberg et al. (2010), but here we are only inter-
ested in selecting the correct SNPs. For this purpose one has the problem to
decide upon the best tuning parameter λ of LASSO. It is well known that
cross validation yields too large models, which we also observed in our simu-
lations. As an alternative we tried to search along the LASSO regularization
path and find the model which minimizes mBIC2, but that gave too small
models. We finally considered a strategy where we searched along the reg-
ularization path for that model which minimizes the misclassification rate.
This is obviously not feasible in practice when the truth is unknown, but
this strategy shows the best possible performance of LASSO that one could
achieve at least theoretically. It still turned out that in our simulations even
the best possible model along the regularization path could not compete with
the models obtained with MOSGWA or HLASSO. We observed that LASSO
tends to select too many correlated SNPs with larger effect sizes, and then
has difficulties to include causal SNPs with smaller effect size, but rather
includes a number of false positives. An explanation of this behavior was
given already by Hoggart et al. (2008) when motivating the NEG prior.
Our simulation study on complex traits showed that at least for our three
scenarios MOSGWA is slightly more powerful than HLASSO, when the pa-
rameter α of HLASSO is chosen such that both procedures have similar type
1 error rate. This reflects the theoretical optimality property of mBIC to
minimize asymptotically the misclassification error under a wide range of
sparsity levels (Frommlet et al., 2011). However, this theoretical property
holds for the model which actually minimizes the criterion mBIC2. Our
heuristic search strategy is attempting to get close to the global minimum,
but we know that in most cases it will fail to find the best solution. More
involved search strategies will further improve our method, and we are cur-
rently exploring the us of memetic algorithms, which have been successfully
applied already in the context of QTL mapping Frommlet et al. (2012a).
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The software architecture of MOSGWA is designed in such a way that
it can be quite easily extended in the future to incorporate more advanced
features. For example it might be interesting to have a model selection pro-
cedure which accounts for population structure. Currently this can be done
by adding principle components as covariates to the regression models, but
an even better solution would be to add random effects to model population
structure. For that reason we are currently working on extending MOSGWA
towards mixed models.
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